The results showed that in contrast to control biopsies that had little or no detectable Egr-1 in the dermis, in SSc biopsies a significant proportion of fibroblastic cells, as well as some vascular cells, showed distinct Egr-1 immunostaining (Fig. 5A). This evidence concerns the gene EGR1 and systemic sclerosis.